½ÃÀ庸°í¼­
»óǰÄÚµå
1521385

¼¼°èÀÇ ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Arrhythmia Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 172 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 83¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 158¾ï 7,000¸¸ ´Þ·¯ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2024-2032³â CAGRÀº 7.46%ÀÔ´Ï´Ù.

ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â´Â ȯÀÚÀÇ ºÎÁ¤¸ÆÀ¸·Î ¾Ë·ÁÁø ºñÁ¤»óÀûÀÎ ½ÉÀå ¸®µëÀ» °¨ÁöÇÏ°í ¸ð´ÏÅ͸µÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ±â±â´Â ȯÀÚÀÇ ÇǺο¡ ºÎÂøµÇ°Å³ª ü³»¿¡ »ðÀÔµÈ Àü±ØÀ» ÅëÇØ ½ÉÀåÀÇ Àü±âÀû Ȱµ¿À» ¿¬¼ÓÀûÀ¸·Î ¶Ç´Â °£ÇæÀûÀ¸·Î ¸ð´ÏÅ͸µÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ½É¹æ¼¼µ¿, ½É½Çºó¸Æ, ¼­¸ÆÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ºÎÁ¤¸ÆÀÇ Áø´Ü ¹× °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ÀÇ·áÁø¿¡°Ô Àû½Ã¿¡ °³ÀÔÇϰí Ä¡·áÇÒ ¼ö ÀÖ´Â ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº Àü ¼¼°è¿¡¼­ °í·ÉÈ­¿Í ÇÔ²² ½ÉÇ÷°ü Áúȯ À¯º´·üÀÌ Áõ°¡Çϸ鼭 ºÎÁ¤¸Æ ¹ß»ý·ü Áõ°¡¿¡ ±â¿©Çϰí ÀÖ´Â °ÍÀ» ¹è°æÀ¸·Î ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. °íÇ÷¾Ð, ´ç´¢, ºñ¸¸ µî À§ÇèÀÎÀÚÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ºñÁ¤»óÀûÀÎ ½ÉÀå ¸®µëÀ» Á¤È®ÇÏ°Ô °¨ÁöÇÏ°í ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¸ð´ÏÅÍ, À̽ÄÇü ½ÉÀå ¸ð´ÏÅÍ(ICM), ¸ð¹ÙÀÏ ½ÉÀå ¿ø°Ý ÃøÁ¤ ½Ã½ºÅÛ(MCT)°ú °°Àº ±â¼ú ¹ßÀü°ú Çõ½ÅÀº Áö¼ÓÀû ÀÎ ¸ð´ÏÅ͸µ°ú ½ÉÀå µ¥ÀÌÅÍÀÇ ¿ø°Ý Àü¼ÛÀ» À§ÇÑ Çâ»óµÈ ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ȯÀÚÀÇ Æí¾ÈÇÔÀ» °³¼±ÇÏ°í ºÎÁ¤¸ÆÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô Çϸç, ÀÇ·áÁøÀÌ ½ÉÀå ÁúȯÀ» ¿¹¹æÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á ¹× È¯ÀÚ Áß½É Ä¡·á ¸ðµ¨·ÎÀÇ ÀüȯÀº ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±âÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ½Ç½Ã°£ ½É¹Ú¼ö µ¥ÀÌÅÍ¿Í ÀáÀçÀûÀÎ ½ÉÀå ÀÌ»ó¿¡ ´ëÇÑ °æ°í¸¦ Á¦°øÇÔÀ¸·Î½á ȯÀÚÀÇ ÇコÄɾ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ȯÀÚ Âü¿©¿Í Ä¡·á ¿ä¹ý ¼øÀÀµµ¸¦ ³ô¿© ÀÓ»ó °á°ú¸¦ °³¼±Çϰí, Áø´ÜµÇÁö ¾Ê°Å³ª Ä¡·áµÇÁö ¾ÊÀº ºÎÁ¤¸ÆÀ¸·Î ÀÎÇÑ ÇÕº´Áõ°ú °ü·ÃµÈ ÀÇ·á ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª »óȯ Á¦ÇѰú ºñ¿ë Á¦¾àÀÌ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç ¸®Æ÷Æ®´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇϰí, ¼¼°è ·¹º§¿¡¼­ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÅøÀº ¼¼°èÀÇ ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ·¹º§ ºÎ¹®¿¡ °üÇÑ »ó¼¼ µ¥ÀÌÅ͸¦ Á¦°øÇϸç, ÀÌ¿¡ µû¶ó Àü·«°¡°¡ ÇâÈÄ ±âȸ¿Í ÇÔ²² °¢°¢ÀÇ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ Å¸±êÃþÀ» ½Äº°Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.

À¯Çüº°

  • ½ÉÀüµµ
  • À̽ÄÇü ¸ð´ÏÅÍ
  • ȦÅÍ ¸ð´ÏÅÍ
  • ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸®

¿ëµµº°

  • ¼­¸Æ
  • ºó¸Æ
  • ½É¹æ¼¼µ¿
  • ½É½Ç¼¼µ¿
  • Á¶±â ¼öÃà
  • ±âŸ

¿ëµµº°

  • º´¿ø ¹× Áø·á¼Ò
  • Áø´Ü ¼¾ÅÍ
  • ±âŸ

Áö¿ªº° ºÐ¼®

º» ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¾ÆÇÁ¸®Ä« ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ÇöÀç ¹× ÇâÈÄ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ÀÌ ¸®Æ÷Æ®¿¡¼­´Â ¸ðµç ÁÖ¿ä Áö¿ª °³°³ ¿ëµµ ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤¡¤¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»ç ÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • À¯Çüº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ½ÉÀü°è
  • À̽ÄÇü ¸ð´ÏÅÍ
  • ȦÅÍ ¸ð´ÏÅÍ
  • ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸®

Á¦6Àå ¼¼°èÀÇ ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ¿ëµµº°
  • ¼­¸Æ
  • ºó¸Æ
  • ½É¹æ¼¼µ¿
  • ½É½Ç¼¼µ¿
  • Á¶±â ¼öÃà
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • ÃÖÁ¾ ¿ëµµº° °³¿ä
  • ÃÖÁ¾ ¿ëµµº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • º´¿ø¡¤Áø·á¼Ò
  • Áø´Ü ¼¾ÅÍ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ ºÎ¹®º°
    • À¯·´ ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º° ¸®½ºÆ®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ±â¾÷ °æÀï ±¸µµ

  • ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • AliveCor Inc.
  • Applied Cardiac Systems
  • BioTelemetry Inc.
  • Biotronik
  • FU.K.Uda Denshi Co. Ltd.
  • GE Healthcare
  • IRhythm
  • Medi-Lynx
  • St. Jude Medical(Abbott)
  • Medtronic
  • Nihon Kohden Corporation
  • Nuubo
  • Spacelabs Healthcare
KSA 24.08.01

The global demand for Arrhythmia Monitoring Devices Market is presumed to reach the market size of nearly USD 15.87 Billion by 2032 from USD 8.31 Billion in 2023 with a CAGR of 7.46% under the study period 2024-2032.

Arrhythmia monitoring devices are medical devices utilized to detect and monitor abnormal heart rhythms, known as arrhythmias, in patients. These devices are designed to continuously or intermittently monitor the heart's electrical activity through electrodes attached to the patient's skin or implanted within the body. These devices play an integral role in diagnosing and managing various arrhythmias, including atrial fibrillation, ventricular tachycardia, and bradycardia, by providing real-time data to healthcare providers for timely intervention and treatment.

MARKET DYNAMICS

The arrhythmia monitoring devices market is experiencing rapid growth fueled by the rising prevalence of cardiovascular diseases, together with the growing aging population globally, which is contributing to the rising incidence of arrhythmias. As the incidence of risk factors such as hypertension, diabetes, and obesity increases, so does the demand for reliable arrhythmia monitoring devices that can accurately detect and monitor abnormal heart rhythms. Technological advancements and innovations such as wearable monitors, implantable cardiac monitors (ICMs), and mobile cardiac telemetry systems (MCTs) offer enhanced capabilities for continuous monitoring and remote transmission of cardiac data. These technological advancements improve patient comfort, enable early detection of arrhythmias, and facilitate healthcare providers' proactive management of cardiac conditions.

Moreover, the shift towards personalized medicine and patient-centric care models drives the adoption of arrhythmia monitoring devices. These devices enable patients to manage their healthcare by providing real-time heart rhythm data and alerts about potential cardiac abnormalities. Enhanced patient engagement and adherence to treatment regimens contribute to enhanced clinical outcomes and reduced healthcare costs associated with complications from undiagnosed or untreated arrhythmias. However, reimbursement limitations and cost constraints may impact market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Arrhythmia Monitoring Devices. The growth and trends of Arrhythmia Monitoring Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Arrhythmia Monitoring Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • ECG
  • Implantable Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry

By Application

  • Bradycardia
  • Tachycardia
  • Atrial Fibrillation
  • Ventricular Fibrillation
  • Premature Contraction
  • Others

By End-use

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Arrhythmia Monitoring Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Arrhythmia Monitoring Devices market include AliveCor Inc., Applied Cardiac Systems, BioTelemetry Inc., Biotronik, FU.K.Uda Denshi Co. Ltd., GE Healthcare, IRhythm, Medi-Lynx, St. Jude Medical (Abbott), Medtronic, Nihon Kohden Corporation, Nuubo, Spacelabs Healthcare. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ARRHYTHMIA MONITORING DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. ECG Historic and Forecast Sales By Regions
  • 5.4. Implantable Monitors Historic and Forecast Sales By Regions
  • 5.5. Holter Monitors Historic and Forecast Sales By Regions
  • 5.6. Mobile Cardiac Telemetry Historic and Forecast Sales By Regions

6. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Bradycardia Historic and Forecast Sales By Regions
  • 6.4. Tachycardia Historic and Forecast Sales By Regions
  • 6.5. Atrial Fibrillation Historic and Forecast Sales By Regions
  • 6.6. Ventricular Fibrillation Historic and Forecast Sales By Regions
  • 6.7. Premature Contraction Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 7.4. Diagnostic Centers Historic and Forecast Sales By Regions
  • 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ARRHYTHMIA MONITORING DEVICES COMPANIES

  • 9.1. Arrhythmia Monitoring Devices Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF ARRHYTHMIA MONITORING DEVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. AliveCor Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Applied Cardiac Systems
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. BioTelemetry Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Biotronik
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. FU.K.Uda Denshi Co. Ltd.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. GE Healthcare
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. IRhythm
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Medi-Lynx
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. St. Jude Medical (Abbott)
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Medtronic
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Nihon Kohden Corporation
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Nuubo
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Spacelabs Healthcare
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦